Dr. Mechoulam’s latest discovery is called EPM301, or cannabidiolic acid methyl ester, also known as CBDa. EPM stands for Endless Potential Molecules, and there are now around 14 patented molecules that are being tested on humans with the US FDAs guidance. The first targets of EPM are psoriasis and inflammatory bowel disease (IBD), which are notoriously difficult to treat.
Try Cornbread Hemp's new USDA-certified organic THC gummy. It's the first hemp THC gummy of…
Register to vote today to make your voice heard. The post Cannabis voter guide to…
We've all heard it before: smoke weed, and you'll become a lazy, unmotivated bum. The…
New THC+CBC Mood Mints from Rare Cannabinoid Company bring on mood-boosting effects quickly thanks to…
Pioneering research from Columbia University in New York suggests that psilocybin, the key component in…
A groundbreaking new study, funded by the Centers for Disease Control and Prevention, suggests exactly…